Literature DB >> 20941477

[69 year-old patient with chronic abdominal pain and anemia in neurofibromatosis].

M Schulz1, A Schreyer, S C Glöckner, J Schölmerich, I Zuber-Jerger.   

Abstract

The case of a patient with neurofibromatosis type 1 with chronic abdominal pain and iron deficiency anemia is described. Diagnostic procedures including esophagogastroduodenoscopy and ileocolonoscopy did not disclose a definitive cause. CT scan and MRI revealed multiple intraluminal tumors in the small bowel, especially in the ileum. These findings were verified by double balloon enteroscopy. Endoscopic resection was not performed due to size and number of the polyps, and the patient was sent for diagnostic laparotomy. A conglomerate tumor of the ileum was resected. Histopathological analysis revealed 13 inflammatory polyps and 2 gastrointestinal stroma tumors.

Entities:  

Mesh:

Year:  2011        PMID: 20941477     DOI: 10.1007/s00108-010-2653-y

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  11 in total

1.  Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population.

Authors:  M E Zöller; B Rembeck; A Odén; M Samuelsson; L Angervall
Journal:  Cancer       Date:  1997-06-01       Impact factor: 6.860

Review 2.  Guidelines for the diagnosis and management of individuals with neurofibromatosis 1.

Authors:  Rosalie E Ferner; Susan M Huson; Nick Thomas; Celia Moss; Harry Willshaw; D Gareth Evans; Meena Upadhyaya; Richard Towers; Michael Gleeson; Christine Steiger; Amanda Kirby
Journal:  J Med Genet       Date:  2006-11-14       Impact factor: 6.318

3.  Mortality in neurofibromatosis 1: an analysis using U.S. death certificates.

Authors:  S A Rasmussen; Q Yang; J M Friedman
Journal:  Am J Hum Genet       Date:  2001-03-28       Impact factor: 11.025

Review 4.  Neurofibromatosis types 1 and 2.

Authors:  Kaleb Yohay
Journal:  Neurologist       Date:  2006-03       Impact factor: 1.398

Review 5.  Genetic aberrations of gastrointestinal stromal tumors.

Authors:  Jilong Yang; Xiaoling Du; Alexander J F Lazar; Raphael Pollock; Kelly Hunt; Kexin Chen; Xishan Hao; Jonathan Trent; Wei Zhang
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

6.  Therapeutic consequences from molecular biology for gastrointestinal stromal tumor patients affected by neurofibromatosis type 1.

Authors:  Chiara Mussi; Hans-Ulrich Schildhaus; Alessandro Gronchi; Eva Wardelmann; Peter Hohenberger
Journal:  Clin Cancer Res       Date:  2008-07-15       Impact factor: 12.531

Review 7.  Diagnosis of gastrointestinal stromal tumors: a consensus approach.

Authors:  Christopher D M Fletcher; Jules J Berman; Christopher Corless; Fred Gorstein; Jerzy Lasota; B Jack Longley; Markku Miettinen; Timothy J O'Leary; Helen Remotti; Brian P Rubin; Barry Shmookler; Leslie H Sobin; Sharon W Weiss
Journal:  Int J Surg Pathol       Date:  2002-04       Impact factor: 1.271

8.  Current status of double balloon endoscopy--indications, insertion route, sedation, complications, technical matters.

Authors:  Shu Tanaka; Keigo Mitsui; Atsushi Tatsuguchi; Tsuyoshi Kobayashi; Akihito Ehara; Katya Gudis; Choitsu Sakamoto
Journal:  Gastrointest Endosc       Date:  2007-09       Impact factor: 9.427

Review 9.  Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review.

Authors:  Markku Miettinen; Mourad Majidi; Jerzy Lasota
Journal:  Eur J Cancer       Date:  2002-09       Impact factor: 9.162

Review 10.  Pathophysiology, diagnosis, and treatment of gastrointestinal stromal tumors.

Authors:  Yasuhisa Shinomura; Kazuo Kinoshita; Shusaku Tsutsui; Seiichi Hirota
Journal:  J Gastroenterol       Date:  2005-08       Impact factor: 6.772

View more
  1 in total

Review 1.  Towards a neurobiological understanding of pain in neurofibromatosis type 1: mechanisms and implications for treatment.

Authors:  Shreya S Bellampalli; Rajesh Khanna
Journal:  Pain       Date:  2019-05       Impact factor: 6.961

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.